Brief: Rein Therapeutics Enters Into Agreements For Up To $21 Million In Flexible Financing
30/07/2025 14:26
July 30 (Reuters) - Rein Therapeutics Inc RNTX.O: REIN THERAPEUTICS ENTERS INTO AGREEMENTS FOR UP TO $21 MILLION IN FLEXIBLE FINANCING REIN THERAPEUTICS INC - PROCEEDS TO SUPPORT RENEW PHASE 2 TRIAL OF LTI-03 FOR IPF Source text: ID:nGNX77pKrw Further company coverage: RNTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering